Abstract
The use of nanodevices to transport active compounds like small-molecular drugs, peptides, or genes found an increased attention throughout the different fields of natural sciences. Moreover, recent research trends are focused on the employment of smart nanocarriers able to react on certain internal or external applied stimuli, in order to achieve temporal and site-specific drugs/gene release. In contrast to traditional biodegradable nanocarriers that slowly release drugs inside the cells, these smart nanosystems are able to quickly release or even dump drugs in response to a specific biological signal in the target cancer cells such lower pH, high redox potential or over expression of enzymes or to external stimuli such as temperature, light, ultrasounds and magnetic field. This review gives a brief overview about some types of stimuli-responsive nanocarriers, with the main focus on magnetic fieldresponsive devices obtained from natural polymers. The concept of magnetic field-sensitive nanocarriers, their advantages and disadvantages, the methods of preparation and applications in various fields of drug delivery will be explored, giving an exhaustive collection of the findings of recent investigations.
Keywords: Nanocarriers, stimuli-responsivity, natural polymers, magnetic nanoparticles.
Current Pharmaceutical Design
Title:Advances on Magnetic Nanocarriers Based on Natural Polymers
Volume: 22 Issue: 22
Author(s): Rita Muzzalupo and Lorena Tavano
Affiliation:
Keywords: Nanocarriers, stimuli-responsivity, natural polymers, magnetic nanoparticles.
Abstract: The use of nanodevices to transport active compounds like small-molecular drugs, peptides, or genes found an increased attention throughout the different fields of natural sciences. Moreover, recent research trends are focused on the employment of smart nanocarriers able to react on certain internal or external applied stimuli, in order to achieve temporal and site-specific drugs/gene release. In contrast to traditional biodegradable nanocarriers that slowly release drugs inside the cells, these smart nanosystems are able to quickly release or even dump drugs in response to a specific biological signal in the target cancer cells such lower pH, high redox potential or over expression of enzymes or to external stimuli such as temperature, light, ultrasounds and magnetic field. This review gives a brief overview about some types of stimuli-responsive nanocarriers, with the main focus on magnetic fieldresponsive devices obtained from natural polymers. The concept of magnetic field-sensitive nanocarriers, their advantages and disadvantages, the methods of preparation and applications in various fields of drug delivery will be explored, giving an exhaustive collection of the findings of recent investigations.
Export Options
About this article
Cite this article as:
Muzzalupo Rita and Tavano Lorena, Advances on Magnetic Nanocarriers Based on Natural Polymers, Current Pharmaceutical Design 2016; 22 (22) . https://dx.doi.org/10.2174/1381612822666160209152214
DOI https://dx.doi.org/10.2174/1381612822666160209152214 |
Print ISSN 1381-6128 |
Publisher Name Bentham Science Publisher |
Online ISSN 1873-4286 |
Call for Papers in Thematic Issues
"Tuberculosis Prevention, Diagnosis and Drug Discovery"
The Nobel Prize-winning discoveries of Mycobacterium tuberculosis and streptomycin have enabled an appropriate diagnosis and an effective treatment of tuberculosis (TB). Since then, many newer diagnosis methods and drugs have been saving millions of lives. Despite advances in the past, TB is still a leading cause of infectious disease mortality ...read more
Current Pharmaceutical challenges in the treatment and diagnosis of neurological dysfunctions
Neurological dysfunctions (MND, ALS, MS, PD, AD, HD, ALS, Autism, OCD etc..) present significant challenges in both diagnosis and treatment, often necessitating innovative approaches and therapeutic interventions. This thematic issue aims to explore the current pharmaceutical landscape surrounding neurological disorders, shedding light on the challenges faced by researchers, clinicians, and ...read more
Emerging and re-emerging diseases
Faced with a possible endemic situation of COVID-19, the world has experienced two important phenomena, the emergence of new infectious diseases and/or the resurgence of previously eradicated infectious diseases. Furthermore, the geographic distribution of such diseases has also undergone changes. This context, in turn, may have a strong relationship with ...read more
Melanoma and Non-Melanoma Skin Cancer Treatment: Standard of Care and Recent Advances
In this thematic issue, we aim to provide a standard of care of the diagnosis and treatment of melanoma and non-melanoma skin cancer. The editor will invite authors from different countries who will write review articles of melanoma and non-melanoma skin cancers. The Diagnosis, Staging, Surgical Treatment, Non-Surgical Treatment all ...read more
- Author Guidelines
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
- Announcements
Related Articles
-
Glycosides from Medicinal Plants as Potential Anticancer Agents: Emerging Trends Towards Future Drugs
Current Medicinal Chemistry The Application of Natural Products in Cancer Therapy by Targeting Apoptosis Pathways
Current Drug Metabolism Regulatory T Cells and Skin Tumors
Recent Patents on Inflammation & Allergy Drug Discovery Paving the Way to Personalized Genomic Medicine: Steps to Successful Implementation
Current Pharmacogenomics and Personalized Medicine Synergistic Effect of the Combination of Novel Suberoylanilide Hydroxamic Acid Derivatives with Cisplatin on Anti-proliferation of Human Cancer Cells
Medicinal Chemistry Recent Advances in Thymidine Kinase 2 (TK2) Inhibitors and New Perspectives for Potential Applications
Current Pharmaceutical Design Tumor Dormancy and the Angiogenic Switch: Possible Implications of Bone Marrow- Derived Cells
Current Pharmaceutical Design Expression and Function of PPARs in Cancer Stem Cells
Current Stem Cell Research & Therapy Advances of Paclitaxel Formulations Based on Nanosystem Delivery Technology
Mini-Reviews in Medicinal Chemistry Vascular Endothelial Growth Factor as an Anti-Angiogenic Target for Cancer Therapy
Current Drug Targets Comparison of Efficacy and Peripheral Neuropathy of Solvent-based Paclitaxel with Paclitaxel Poliglumex and NK105: A Systematic Review and Metaanalysis
Current Pharmaceutical Design Editorial (Thematic Issue: <i>In Silico</i> Drug Design and Medicinal Chemistry)
Current Topics in Medicinal Chemistry Exploiting Cyclooxygenase-(in)Dependent Properties of COX-2 Inhibitors for Malignant Glioma Therapy
Anti-Cancer Agents in Medicinal Chemistry Update on the Use of Biologics in Lupus
Current Pharmaceutical Biotechnology Engineered Peptides for Applications in Cancer-Targeted Drug Delivery and Tumor Detection
Mini-Reviews in Medicinal Chemistry EXTraordinary Bones: Functional and Genetic Analysis of the EXT Gene Family
Current Genomics HIF-1α Modulates Energy Metabolism in Cancer Cells by Inducing Over-Expression of Specific Glycolytic Isoforms
Mini-Reviews in Medicinal Chemistry Absorption, Pharmacokinetics and Disposition of Biodegradable Nanoscale Preparations
Current Drug Metabolism Inhibition of Aurora A Kinase by Alisertib Induces Autophagy and Cell Cycle Arrest and Increases Chemosensitivity in Human Hepatocellular Carcinoma HepG2 Cells
Current Cancer Drug Targets Withdrawal Notice: Emerging Biomarkers and Contributing Factors of Prostate Cancer
Current Cancer Therapy Reviews